Toyochem Develops Soft Skin Polyurethane-based Pressure-Sensitive Adhesives

February 24, 2021

Toyochem Co. has released a new line of “Soft Skin” polyurethane-based pressure-sensitive adhesives (PSAs) designed to meet the growing demand for safe, low-trauma medical devices formulated for sensitive skin individuals. Suitable applications include surgical tapes and dressing films customized for the medical and healthcare fields.

The new adhesive system offers high moisture permeability and low skin exfoliation for pain-free removal or repositioning of the adhesive material. In addition, the new compositions do not contain silicones or other substances that may contaminate coatings lines or processing environments.
Drawing on its expertise in urethane chemistry in the development of protective films for the electronics industry, Toyochem engineered a medical-grade urethane composition with a uniquely soft and flexible urethane-based composition. The product adheres well to the skin while causing very low trauma to the keratin layer when the dressing is removed or repositioned. “The challenge is finding the right balance between adhesion and release,” said Nao Nakamura, general manager of Toyochem’s adhesives division.
Nakamura added, “Materials for medical devices and dressing must have the elasticity to conform to skin surfaces and movement in order to prevent water, dirt, or bacteria from entering and infecting the wound. They also need to have the right amount of release to prevent trauma to the tender skin surrounding it. With the new development, we’re able to strike a fine balance that meets both requirements.”
Moreover, Toyochem’s new urethane PSA system demonstrates exceptional moisture permeability with water vapor transmission rates of 2,000g/m2/24 hours, achieving values that are considerably higher than those of conventional acrylic PSAs. Poor moisture permeability can trap heat and water vapors between the skin and adhesive layer, often leading to skin irritation, maceration, and even bacterial growth. Toyochem’s PSA product, however, is designed to substantially raise the water vapor transmission ability of the adhesive layer, allowing moisture to be evaporated to the outside of the adhesive material.
At present, silicones are widely used in the manufacturing of wound management devices, due to their biocompatibility. The new PSAs from Toyochem, however, is silicone-free and have been proven safe for human skin contact. They can be customized to meet International Standards ISO 10993-1, making it a more user- and cost-friendly alternative to silicone adhesives.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.